{"filing":{"accession_number":"0001213900-26-091438","cik":"0001139685","ticker":"AIDX","company_name":"20/20 Biolabs, Inc.","form":"8-K","filing_date":"2026-08-19","report_date":"2026-08-18","primary_document":"ea0302628-8k_2020bio.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1139685/000121390026091438/ea0302628-8k_2020bio.htm"},"events":[{"id":28441,"run_id":26018,"accession_number":"0001213900-26-091438","anchor_item_number":"5.07","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.95,"summary":"This is a clear disclosure of shareholder vote results from the August 18, 2026 annual meeting under Item 5.07. The filing reports voting outcomes for five proposals: election of six directors (Proposal 1), ratification of auditor dbbmckennon (Proposal 2), approval of the 2026 Equity Incentive Plan (Proposal 4), and approval of adjournment authority (Proposal 5), with Proposal 3 (Charter Amendment) deferred to September 16, 2026 due to insufficient votes. The detailed vote tallies for each proposal and director candidate are provided, making this a standard shareholder vote results disclosure material to investors assessing governance and capital allocation decisions.","company_name":"20/20 Biolabs, Inc.","ticker":"AIDX","filing_date":"2026-08-19","form":"8-K","submitted_at":null,"items":[{"id":30389,"accession_number":"0001213900-26-091438","item_number":"5.07","item_title":"Submission of Matters to a Vote of Security Holders.","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.95,"reasoning":"This is a clear disclosure of shareholder vote results from the August 18, 2026 annual meeting under Item 5.07. The filing reports voting outcomes for five proposals: election of six directors (Proposal 1), ratification of auditor dbbmckennon (Proposal 2), approval of the 2026 Equity Incentive Plan (Proposal 4), and approval of adjournment authority (Proposal 5), with Proposal 3 (Charter Amendment) deferred to September 16, 2026 due to insufficient votes. The detailed vote tallies for each proposal and director candidate are provided, making this a standard shareholder vote results disclosure material to investors assessing governance and capital allocation decisions.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-19T13:19:38.470624+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":30389,"accession_number":"0001213900-26-091438","item_number":"5.07","item_title":"Submission of Matters to a Vote of Security Holders.","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.95,"reasoning":"This is a clear disclosure of shareholder vote results from the August 18, 2026 annual meeting under Item 5.07. The filing reports voting outcomes for five proposals: election of six directors (Proposal 1), ratification of auditor dbbmckennon (Proposal 2), approval of the 2026 Equity Incentive Plan (Proposal 4), and approval of adjournment authority (Proposal 5), with Proposal 3 (Charter Amendment) deferred to September 16, 2026 due to insufficient votes. The detailed vote tallies for each proposal and director candidate are provided, making this a standard shareholder vote results disclosure material to investors assessing governance and capital allocation decisions.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-19T13:19:38.470624+00:00","company_name":"20/20 Biolabs, Inc.","ticker":"AIDX","filing_date":"2026-08-19"}]}